ArriVent BioPharma Stock Quote AVBP - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

18.42

Bid

10.80

Ask

24.11

Volume

48,173

18.08 Day's Range 18.85

14.35 52 Week Range 25.5076

Market Cap

624.993M

Previous Close

18.66

Open

18.55

Last Trade

393

18.42

(formt)

Last Trade Time

Financial Volume

$ 893,703

VWAP

18.5519

Average Volume (3m)

76,938

Shares Outstanding

33,493,750

Dividend Yield

PE Ratio

-8.99

Earnings Per Share (EPS)

-2.07

Revenue

Net Profit

-69.33M

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therap... ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers. It also engages in the development and commercialization of targeted cancer therapies for non-small-cell lung cancer (NSCLC) and other solid tumors. The company develops Furmonertinib, an epidermal growth factor receptor mutant-selective tyrosine kinase inhibitor that is in phase 3 clinical trial for the treatment of NSCLC patients; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

arrivent.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

ArriVent BioPharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker AVBP. The last closing price for ArriVent BioPharma was $18.66. Over the last year, ArriVent BioPharma shares have traded in a share price range of $ 14.35 to $ 25.5076.

ArriVent BioPharma currently has 33,493,750 shares outstanding. The market capitalization of ArriVent BioPharma is $624.99 million. ArriVent BioPharma has a price to earnings ratio (PE ratio) of -8.99.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.24	1.3201320132	18.18	19.91	17.29	68851	18.53633397	CS
4	-0.31	-1.65509877202	18.73	19.91	15.53	78939	18.12424704	CS
12	1.4699	8.67192523938	16.9501	21	14.35	76938	17.39201508	CS
26	-5.58	-23.25	24	25.5076	14.35	148806	19.08878378	CS
52	-5.58	-23.25	24	25.5076	14.35	148806	19.08878378	CS
156	-5.58	-23.25	24	25.5076	14.35	148806	19.08878378	CS
260	-5.58	-23.25	24	25.5076	14.35	148806	19.08878378	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SNGXSoligenix Inc	$ 7.42 (271.00%)	134.1M
ZAPPZapp Electric Vehicles Group Ltd	$ 17.9001 (93.72%)	45.47M
PEGYPineapple Energy Inc	$ 2.30 (91.67%)	77.43M
ATNF180 Life Sciences Corporation	$ 2.9017 (79.12%)	31.2M
QUREuniQure NV	$ 6.65 (75.93%)	51.49M
NVOSNovo Integrated Sciences Inc	$ 0.4874 (-35.44%)	3.11M
FAASDigiAsia Corporation	$ 3.65 (-34.17%)	48.97k
INDVIndivior PLC	$ 10.18 (-33.64%)	2.95M
CLEUChina Liberal Education Holdings Ltd	$ 0.3905 (-31.59%)	9.22M
HELEHelen of Troy Ltd	$ 64.30 (-27.76%)	5.47M
NVDANVIDIA Corporation	$ 131.38 (2.48%)	286.78M
MAXNMaxeon Solar Technologies Ltd	$ 0.2451 (-9.22%)	232.72M
TSLATesla Inc	$ 262.33 (3.71%)	160.63M
SNGXSoligenix Inc	$ 7.42 (271.00%)	134.1M
INTCIntel Corporation	$ 34.59 (1.77%)	97.76M